Neurotec Pharma

company

About

Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€3.30M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Neurotec Pharma SL is a spin-off of the University of Barcelona (UB) founded in 2006 and based in the Parc Científic de Barcelona (PCB).

Neurotec centers its activity on developing new treatments for acute and chronic Central Nervous System (CNS) diseases. The proposed innovations are based in the possibility of controlling the activity of the microglia cells that are implicated in a wide group of diseases related to inflammation or acute cerebral damage.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.30M
Neurotec Pharma has raised a total of €3.30M in funding over 2 rounds. Their latest funding was raised on Feb 19, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 19, 2011 Series Unknown €3.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Neurotec Pharma is funded by 1 investors. Fundación Caja Navarra are the most recent investors.
Investor Name Lead Investor Funding Round
Fundación Caja Navarra Series Unknown